Mirati Therapeutics, in collaboration with Array BioPharma (Pfizer) and Monoceros Biosystems, published a novel Nature Medicine article entitled “Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor“
Mirati Therapeutics, in collaboration with Array BioPharma (Pfizer) and Monoceros Biosystems, published a novel Nature Medicine article entitled “Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor“